NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Larsen & Toubro Ltd Sees Subdued Q4FY26 Performance Amid Execution Challenges

Larsen & Toubro Ltd (L&T) has reported a relatively subdued operating performance in the fourth quarter of fiscal year 2026 (Q4FY26), as execution challenges and cost pressures weighed on profitability despite healthy revenue growth. The company's consolidated revenue increased 11.3% year-over-year (YoY) to ₹828 billion, falling short of L&T's earlier expectation of around 15% growth.

The operating performance was impacted by a decline in the Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) margin for the quarter, which contracted 62 basis points (bps) YoY to 10.4%. This decline was primarily due to an unfavourable execution mix and higher operating costs. Within the core Engineering and Construction (E&C) segment, the EBITDA margin contracted 50 bps YoY to 9.4%, primarily due to elevated logistics and insurance expenses along with a changing revenue mix. On a fiscal year 2026 (FY26) basis, the core EBITDA margin stood at 8.3%, slightly below management's guidance of 8.5%.

Management also indicated that geopolitical disruptions in the Middle East impacted execution during March, typically a peak execution month, resulting in an estimated revenue loss of around ₹50 billion in Q4FY26. However, the management clarified that no projects have been cancelled and payment cycles remain intact.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Maintaining BUY Rating and Revised Target Price

Despite the subdued Q4FY26 performance, L&T's strong order backlog, improving capital efficiency, and long-term growth visibility across core and emerging businesses support the company's outlook. As a result, we maintain our BUY rating on the company with a revised target price of ₹4,620, valuing the core business at 23x fiscal year 2028 estimated earnings per share (EPS).

Comparison of Q4FY26 PerformanceActualGuidance
Consolidated Revenue Growth (YoY)11.3%15%
EBITDA Margin (Q4FY26)10.4%-
EBITDA Margin (FY26)8.3%8.5%
Revised Target Price (₹)4,620-
Valuation Multiple (x FY28E EPS)23x-

Investor Takeaway

Investors should be cautious about the company's performance due to execution challenges and cost pressures.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.